Patents by Inventor Collin Bachert

Collin Bachert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell-based screening and compounds that modulate GalNAc-transferases
    Patent number: 11730730
    Abstract: Provided herein are small molecule-inhibitors of site-specific O-glycosylation and the identification of such using cell-based fluorescent biosensors. Also provided herein are methods of treating kidney disease and cancer, such as breast cancer.
    Type: Grant
    Filed: May 26, 2021
    Date of Patent: August 22, 2023
    Assignee: Carnegie Mellon University
    Inventors: Adam D. Linstedt, Lina Song, Collin Bachert
  • Cell-Based Screening and Compounds that Modulate GalNAc-Transferases
    Publication number: 20210283124
    Abstract: Provided herein are small molecule-inhibitors of site-specific O-glycosylation and the identification of such using cell-based fluorescent biosensors. Also provided herein are methods of treating kidney disease and cancer, such as breast cancer.
    Type: Application
    Filed: May 26, 2021
    Publication date: September 16, 2021
    Inventors: Adam D. Linstedt, Lina Song, Collin Bachert
  • Cell-based screening and compounds that modulate GaINAc-transferases
    Patent number: 11058675
    Abstract: Provided herein are small molecule-inhibitors of site-specific O-glycosylation and the identification of such using cell-based fluorescent biosensors. Also provided herein are methods of treating kidney disease and cancer, such as breast cancer.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: July 13, 2021
    Assignee: Carnegie Mellon University
    Inventors: Adam D. Linstedt, Lina Song, Collin Bachert
  • Cell-Based Screening and Compounds that Modulate GalNAc-Transferases
    Publication number: 20190298711
    Abstract: Provided herein are small molecule-inhibitors of site-specific O-glycosylation and the identification of such using cell-based fluorescent biosensors. Also provided herein are methods of treating kidney disease and cancer, such as breast cancer.
    Type: Application
    Filed: March 29, 2019
    Publication date: October 3, 2019
    Inventors: Adam D. Linstedt, Lina Song, Collin Bachert